ALINAMIN EX GOLD

Serial Number 87732163
Registration 5707118
700

Registration Progress

Application Filed
Dec 22, 2017
Under Examination
Approved for Publication
Jan 8, 2019
Published for Opposition
Jan 8, 2019
Registered
Mar 26, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-03-26) (Grace Period Filing)
Due: Sep 26, 2025 Grace Period - 58 days
Original deadline was Mar 26, 2025 (overdue)

Trademark Image

ALINAMIN EX GOLD

Basic Information

Serial Number
87732163
Registration Number
5707118
Filing Date
December 22, 2017
Registration Date
March 26, 2019
Published for Opposition
January 8, 2019
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 26, 2019
Registration
Registered
Classes
005

Rights Holder

ALINAMIN PHARMACEUTICAL CO., LTD.

03
Address
8-2, MARUNOUCHI 1-CHOME, CHIYODA-KU
TOKYO 100-0005
JP

Ownership History

Takeda Consumer Healthcare Company Limited

Original Applicant
03
Tokyo 100-0005 JP

Takeda Consumer Healthcare Company Limited

Owner at Publication
03
Tokyo 100-0005 JP

Takeda Consumer Healthcare Company Limited

Original Registrant
03
Tokyo 100-0005 JP

ALINAMIN PHARMACEUTICAL CO., LTD.

New Owner After Registration #1
03
TOKYO JP

Legal Representation

Attorney
Bassam N. Ibrahim

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-03-26)
Due Date
March 26, 2025
Grace Period Ends
September 26, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Mar 26, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
May 19, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Mar 26, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 8, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 8, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 19, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 30, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 28, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 28, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 27, 2018 ALIE A ASSIGNED TO LIE Loading...
Nov 16, 2018 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Aug 8, 2018 CNSL R SUSPENSION LETTER WRITTEN Loading...
Aug 8, 2018 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Aug 8, 2018 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jul 19, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 18, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 18, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 5, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 5, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 5, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 4, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 10, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 26, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for human use, namely, for the relief of muscular pain, shoulder stiffness, lumbar pain and eyestrain; vitamin preparations; nutritional additives for medical purposes in the nature of dietary supplements; dietetic beverages, namely, energy drinks adapted for medical purposes; dietary supplement drinks for medical purposes
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005